questionsmedicales.fr
Maladies du système immunitaire
Déficits immunitaires
Agammaglobulinémie
Agammaglobulinémie : Questions médicales fréquentes
Diagnostic
5
Agammaglobulinémie
Immunodéficience
Tests sanguins
Électrophorèse
Immunoglobulines
Tests diagnostiques
Antécédents médicaux
Agammaglobulinémie
Hérédité
Agammaglobulinémie
Diagnostic
Pédiatrie
Infections
Agammaglobulinémie
Symptômes
Symptômes
5
Symptômes
Infections
Retard de croissance
Infections
Agammaglobulinémie
Hospitalisation
Enfants
Infections respiratoires
Otite
Fatigue
Agammaglobulinémie
Infections
Variabilité
Symptômes
Agammaglobulinémie
Prévention
5
Prévention
Infections
Hygiène
Vaccinations
Agammaglobulinémie
Prévention
Alimentation
Système immunitaire
Prévention
Prévention
Infections
Lieux publics
Soins dentaires
Infections
Prévention
Traitements
5
Immunothérapie
Immunoglobulines
Traitement
Antibiotiques
Prévention
Infections
Thérapie génique
Traitements expérimentaux
Agammaglobulinémie
Immunothérapie
Intraveineuse
Sous-cutanée
Traitement à vie
Agammaglobulinémie
Gestion
Complications
5
Complications
Infections
Maladies auto-immunes
Infections
Mortalité
Agammaglobulinémie
Cancer
Agammaglobulinémie
Risque accru
Maladies auto-immunes
Agammaglobulinémie
Complications
Gestion
Complications
Suivi médical
Facteurs de risque
5
Facteurs de risque
Hérédité
Agammaglobulinémie
Âge
Agammaglobulinémie
Enfants
Infections
Agammaglobulinémie
Facteurs de risque
Environnement
Facteurs de risque
Agammaglobulinémie
Maladies auto-immunes
Agammaglobulinémie
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agammaglobulinémie : Questions médicales les plus fréquentes",
"headline": "Agammaglobulinémie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agammaglobulinémie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-14",
"dateModified": "2026-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agammaglobulinémie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Déficits immunitaires",
"url": "https://questionsmedicales.fr/mesh/D007153",
"about": {
"@type": "MedicalCondition",
"name": "Déficits immunitaires",
"code": {
"@type": "MedicalCode",
"code": "D007153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.673"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Agammaglobulinémie",
"alternateName": "Agammaglobulinemia",
"code": {
"@type": "MedicalCode",
"code": "D000361",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hirokazu Kanegane",
"url": "https://questionsmedicales.fr/author/Hirokazu%20Kanegane",
"affiliation": {
"@type": "Organization",
"name": "Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-3-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan. hkanegane.ped@tmd.ac.jp."
}
},
{
"@type": "Person",
"name": "Hans D Ochs",
"url": "https://questionsmedicales.fr/author/Hans%20D%20Ochs",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, WA, USA."
}
},
{
"@type": "Person",
"name": "Tomohiro Morio",
"url": "https://questionsmedicales.fr/author/Tomohiro%20Morio",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-3-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Kohsuke Imai",
"url": "https://questionsmedicales.fr/author/Kohsuke%20Imai",
"affiliation": {
"@type": "Organization",
"name": "Department of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Kathleen E Sullivan",
"url": "https://questionsmedicales.fr/author/Kathleen%20E%20Sullivan",
"affiliation": {
"@type": "Organization",
"name": "Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39271984",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-024-09743-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Discordant Phenotypes of Nephritis in Patients with X-linked Agammaglobulinemia.",
"datePublished": "2024-07-25",
"url": "https://questionsmedicales.fr/article/39052129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10875-024-01766-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Disseminated Aspergillosis in X-linked Agammaglobulinemia: Beyond the norm.",
"datePublished": "2024-10-15",
"url": "https://questionsmedicales.fr/article/39404906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10875-024-01815-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Case report of renal manifestations in X-linked agammaglobulinemia.",
"datePublished": "2024-07-25",
"url": "https://questionsmedicales.fr/article/39119334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1376258"
}
},
{
"@type": "ScholarlyArticle",
"name": "IgA nephropathy in a child with X-linked agammaglobulinemia: a case report.",
"datePublished": "2024-04-30",
"url": "https://questionsmedicales.fr/article/38689221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-024-04746-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Déficits immunitaires",
"item": "https://questionsmedicales.fr/mesh/D007153"
},
{
"@type": "ListItem",
"position": 4,
"name": "Agammaglobulinémie",
"item": "https://questionsmedicales.fr/mesh/D000361"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agammaglobulinémie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agammaglobulinémie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agammaglobulinémie",
"description": "Comment diagnostiquer l'agammaglobulinémie ?\nQuels tests sont utilisés pour le diagnostic ?\nL'historique médical est-il important ?\nPeut-on diagnostiquer à tout âge ?\nQuels symptômes peuvent alerter au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agammaglobulinémie",
"description": "Quels sont les symptômes courants ?\nLes infections sont-elles graves ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment se manifeste la fatigue ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agammaglobulinémie",
"description": "Comment prévenir les infections ?\nLes vaccinations sont-elles sûres ?\nY a-t-il des conseils diététiques ?\nLes patients doivent-ils éviter des lieux publics ?\nDes soins dentaires réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agammaglobulinémie",
"description": "Quel est le traitement principal ?\nLes antibiotiques sont-ils nécessaires ?\nY a-t-il des traitements expérimentaux ?\nComment se déroule l'immunothérapie ?\nLes traitements sont-ils à vie ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agammaglobulinémie",
"description": "Quelles sont les complications possibles ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il un risque accru de cancer ?\nLes maladies auto-immunes sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agammaglobulinémie",
"description": "Quels sont les facteurs de risque génétiques ?\nL'âge joue-t-il un rôle ?\nLes infections antérieures influencent-elles le risque ?\nY a-t-il des facteurs environnementaux ?\nLes maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000361#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'agammaglobulinémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins mesurant les niveaux d'anticorps."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrophorèse des protéines et la mesure des immunoglobulines."
}
},
{
"@type": "Question",
"name": "L'historique médical est-il important ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'historique médical familial peut aider à identifier des cas d'agammaglobulinémie."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer à tout âge ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agammaglobulinémie est souvent diagnostiquée dans l'enfance, mais peut être identifiée plus tard."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des infections fréquentes et graves peuvent indiquer une agammaglobulinémie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des infections récurrentes, fatigue et retard de croissance."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles graves ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent être graves et nécessiter une hospitalisation fréquente."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des infections respiratoires fréquentes et des otites."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut être due à des infections chroniques et à un effort immunitaire constant."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la fréquence des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des vaccinations et des soins médicaux réguliers."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles sûres ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations sont recommandées, mais d'autres peuvent être évitées selon le cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut renforcer le système immunitaire et aider à la santé globale."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter des lieux publics ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les foules peut réduire le risque d'infections, surtout en période épidémique."
}
},
{
"@type": "Question",
"name": "Des soins dentaires réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins dentaires réguliers aident à prévenir les infections buccales et systémiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'immunothérapie par administration d'immunoglobulines."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques prophylactiques peuvent être prescrits pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Comment se déroule l'immunothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunothérapie se fait par voie intraveineuse ou sous-cutanée, selon le cas."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils à vie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients nécessitent souvent un traitement à vie pour gérer leur condition."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections graves, des maladies auto-immunes et des cancers."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être mortelles sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru de certains types de cancer."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer des maladies auto-immunes en raison de l'immunodéficience."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'agammaglobulinémie augmentent le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'agammaglobulinémie est plus fréquente chez les jeunes enfants et les nourrissons."
}
},
{
"@type": "Question",
"name": "Les infections antérieures influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent augmenter le risque d'agammaglobulinémie chez les individus vulnérables."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux, comme l'exposition à des toxines, peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des maladies auto-immunes peuvent avoir un risque accru d'agammaglobulinémie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2026
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-3-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan. hkanegane.ped@tmd.ac.jp.
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics, University of Washington, Seattle Children's Research Institute, Seattle, WA, USA.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-3-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Department of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Division of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, PA.
Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA.
Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Publications dans "Agammaglobulinémie" :
4 publications dans cette catégorie
Affiliations :
Flow Cytometry Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Research Center for Primary Immunodeficiencies, Iran University of Medical Sciences, Tehran, Iran
Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Science, Tehran, Iran
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Translational and Clinical Research Institute, Newcastle University, and Paediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Division of Allergy and Clinical Immunology, Departments of Medicine and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohematology, K.E.M Hospital, Mumbai, India.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Pediatrics Clinic and Institute of Molecular Medicine A. Novicelli, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
Publications dans "Agammaglobulinémie" :
3 publications dans cette catégorie
Affiliations :
Cytogenetic and Medical Genetics Unit, "A. Nocivelli" Institute for Molecular Medicine Spedali Civili Hospital, Brescia, Italy.
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Publications dans "Agammaglobulinémie" :
2 publications dans cette catégorie
Affiliations :
Internal Medicine/Pediatrics, Acom/Southeast Health, Dothan, USA.
Publications dans "Agammaglobulinémie" :
2 publications dans cette catégorie
Affiliations :
Hospital Medicine, Southeast Health Medical Center, Dothan, USA.
Publications dans "Agammaglobulinémie" :
X-linked agammaglobulinemia (XLA), also referred to as Bruton's tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system. We conducted genetic analysis on patients sufferi...
To define the clinical and histological characteristics of nephritis in patients with X-linked agammaglobulinemia (XLA) and their immunological profiles....
The clinical, immunological, and histological findings of nine patients with XLA and nephritis were retrospectively analyzed....
Based on kidney histological findings, patients with XLA and nephritis could be divided into two groups, viz., chronic glomerulonephritis (CGN) and tubulointerstitial nephritis (TIN). The two groups s...
Nephritis occurring in patients with XLA could have links between their renal pathology and immunological status. Careful observation is recommended to detect kidney pathology in patients with XLA on ...
X-linked agammaglobulinemia (XLA) due to a mutation in Bruton's tyrosine kinase (BTK), leads to the arrested development of B cells at the pro-B cell stage. This results in absent B cells and severe h...
X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency disorder characterized by recurrent infections, severe hypogammaglobulinemia, and a deficiency of circulating B cells. While the hallmar...
The two cases described involve twin brothers, both presenting with respiratory tract infections and renal manifestations. Subsequent genetic testing confirmed the diagnosis of XLA. The younger brothe...
Immune profiling and genetic testing should be considered in male children with recurrent infections to facilitate the effective diagnosis of XLA. Regular monitoring is also imperative to detect and t...
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency disease caused by mutations in the Bruton tyrosine kinase (BTK) gene. Individuals diagnosed with XLA are at an increased risk of develop...
In this report, we discussed a specific case involving a 6-year-old boy with XLA who experienced recurrent upper respiratory tract infections since the age of one. He presented with symptoms of hematu...
In this study, we describe the first case of IgA nephropathy associated with XLA. This is an interesting phenotype found in XLA, and it provides valuable insights into the process of autoimmunity and ...
Bezold's abscess is an extracranial complication of otitis media, in which a cervical abscess forms from the mastoid process through an ostial fistula, and is a rare condition in recent years. In this...
X-linked agammaglobulinemia (XLA) is an inborn error of immunity caused by variants in Bruton's tyrosine kinase (BTK). XLA patients require lifelong immunoglobulin replacement therapy (IgRT). Only few...
XLA patients were recruited through a questionnaire and a literature review. The data are on patient characteristics and transplantation methods and outcomes....
In this study, twenty-two XLA patients who underwent HCT were recruited. The indication for HCT was recurrent or life-threatening infection in sixteen patients, malignancy in three, and other factors ...
Based on the concept in which IgRT is the standard treatment for XLA, HCT may be an effective and safe alternative treatment option for XLA patients, and IgRT can be discontinued following transplanta...
To understand the natural history and clinical outcomes for patients with X-linked agammaglobulinemia (XLA) in the United States utilizing the United States Immunodeficiency Network (USIDNET) patient ...
The USIDNET registry was queried for data from XLA patients collected from 1981 to 2019. Data fields included demographics, clinical features before and after diagnosis of XLA, family history, genetic...
Data compiled through the USIDNET registry on 240 patients were analyzed. Patient year of birth ranged from 1945 to 2017. Living status was available for 178 patients; 158/178 (88.8%) were alive. Race...
Current therapies for XLA patients reduce early mortality, but patients continue to experience complications that impact organ function. With improved life expectancy, more efforts will be required to...
Bruton's tyrosine kinase (BTK) is a cytoplasmic protein involved in the B cell development. X-linked agammaglobulinemia (XLA) is caused by mutation in the...
Twenty-two patients (from 16 unrelated families) were molecularly diagnosed as XLA. Genetic testing revealed fifteen distinct mutations, including four splicing mutations, four missense mutations, thr...
This report provides the first overview of demographic, clinical, immunological and genetic data of XLA in Malaysia. The combination of flow cytometric assessment and...
In 1952, X-linked agammaglobulinemia (XLA) was discovered as a rare inherited disorder. It markedly compromises the ability of the body to combat infectious microorganisms. Membranoproliferative glome...